Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02616 CSTONE PHARMA-B
RT Nominal down10.870 -0.930 (-7.881%)
Latest  |  Final  |  Interim
Non-current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others88,624-4.928%93,218105,664138,379154,166
Land & other Lease Assets21,361-42.770%37,32547,70468,18728,631
Intangible Assets155,526-3.619%161,366173,045159,69970,539
Interests in Asso. & JCEs0--0000
Other Non-current Assets24,905113.795%11,6495,79925,24560,472

290,416-4.329%303,558332,212391,510313,808
Current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Inventories148,851-47.972%286,096108,82822,18861,363
Trade Receivables62,536-25.489%83,929172,43877,133117,598
Cash & Bank Balances457,76618.000%387,937996,671558,684742,724
Other Current Assets232,336-30.008%331,94651,850588,9121,035,960
Assets Held for Sale0--0000

901,489-17.288%1,089,9081,329,7871,246,9171,957,645
Current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Trade Payables212,085-37.258%338,029315,106290,414414,293
S-T Debt & Leases219,947135.954%93,216139,31344,91843,948
Other Current Liabilities193,764-22.730%250,761395,919611,150474,707
Liab asso w/ Assets Held for Sale0--0000

625,796-8.242%682,006850,338946,482932,948
Net Current Assets275,693-32.412%407,902479,449300,4351,024,697
Total Assets Less Current Liabilities566,109-20.430%711,460811,661691,9451,338,505
Non-current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
L-T Debt & Leases171,426-34.759%262,757224,135241,372130,250
Other Non-current Liabilities79,639-6.122%84,832130,6961,2471,247

251,065-27.770%347,589354,831242,619131,497
Capital and Reserves
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
  Share Capital9186.744%860860802796
  Reserves314,126-13.467%363,011455,970448,5241,206,212
  Others0--0000
Shareholders' Funds315,044-13.419%363,871456,830449,3261,207,008
Non-controlling Interests0--0000
Others0--0000

315,044-13.419%363,871456,830449,3261,207,008
Commitments and Contingent Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Commitments----00034,690
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 11/09/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -270,183
%Change--
EPS / (LPS)RMB -0.210
NBV Per Share (¥)RMB 0.231
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.